Literature DB >> 6388064

The effect of salt intake on cyclosporine-induced impairment of renal function in rats.

J F Gerkens, S B Bhagwandeen, P J Dosen, A J Smith.   

Abstract

Three groups of rats were fed a low-sodium diet. Groups 1 drank water and was treated with cyclosporine, 100 mg kg-1 48 h-1 p.o. for 3 weeks (low-salt-treated group). Group 2 drank 0.15 M saline and was also treated with cyclosporine (high-salt-treated group). Group 3 drank water and was treated with the vehicle (low-salt-vehicle group). Measurements were made during a control period and weekly during the 3-week treatment period and a 3-week recovery period. Both cyclosporine-treated groups lost weight during treatment but the rises in serum creatinine and blood urea and decrease in creatinine clearance were greater in the low-salt group. The vehicle group gained weight and had no change in the other parameters over the three weeks. There was an increase in urine volume and sodium excretion in the high-salt group associated with cyclosporine treatment. Although the low-salt groups had a higher plasma renin concentration than the high-salt group there were no changes produced by cyclosporine treatment. Histopathological examination showed mild tubular lesions with vacuolar degeneration of proximal tubular cells. This was more prevalent in the low-salt-cyclosporine-treated group. The plasma concentrations of cyclosporine were not different after one-week treatment but were slightly greater after 2 week and 3-week treatment in the low-salt group. We have suggested that the greater impairment of renal function in the low-salt group produced by cyclosporine may be contributed to by an involvement of tubuloglomerular feedback.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388064     DOI: 10.1097/00007890-198410000-00019

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

1.  Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.

Authors:  N G Moss; S L Powell; R J Falk
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 2.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.

Authors:  R G del Moral; M Andujar; C Ramírez; M Gómez-Morales; M Masseroli; M Aguilar; A Olmo; F Arrebola; M Guillén; M J García-Chicano; F F Nogales; F O'Valle
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

4.  Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Authors:  J B Roullet; H Xue; D A McCarron; S Holcomb; W M Bennett
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity.

Authors:  F T McAuley; J G Simpson; A W Thomson; P H Whiting
Journal:  Agents Actions       Date:  1987-06

6.  Renal injury induced by long-term administration of cyclosporin A to rats.

Authors:  T Bertani; N Perico; M Abbate; C Battaglia; G Remuzzi
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

7.  Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.

Authors:  P H Whiting; N Barnard; A Neilsch; J G Simpson; M D Burke
Journal:  Br J Exp Pathol       Date:  1987-12

Review 8.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.